NVP-BSK-805 | Interleukin Related interleukin-related.com

Product Name :
NVP-BSK-805

Search keywords :
NVP-BSK805

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK2

Target Vo Short Name :
JAK2

Moa_Name:
Tyrosine-protein kinase JAK2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Myeloproliferative Disorders

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HtrA2 Antibody (YA726)
Aquaporin 4 Antibody
BRG1 Antibody (YA817): BRG1 Antibody (YA817) is a non-conjugated and Mouse origined monoclonal antibody about 185 kDa, targeting to BRG1 (6D7). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts